ArticleMolecular imaging and biology2015

A Synthetic Heterobivalent Ligand Composed of Glucagon-Like Peptide 1 and Yohimbine Specifically Targets β Cells Within the Pancreas.

Leah V Steyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.